Company Filing History:
Years Active: 2011
Title: **Innovator Hans-Peter Elsässer: Pioneering Biologically Tolerated Polyethylenimines**
Introduction
Hans-Peter Elsässer is an accomplished inventor based in Marburg, Germany. With a focus on biochemistry and biotechnology, he has made significant contributions to the field through his innovative research and development efforts.
Latest Patents
Elsässer holds a pivotal patent for "Biologically tolerated low molecular weight polyethylenimines." This invention revolves around low molecular weight polyethylenimines and their utilization as vectors for inserting nucleic acids into cells. The specific formulation involves polyethylenimines with a molecular weight of less than 50,000 Da, enhancing their efficiency and biocompatibility in nucleic acid delivery systems.
Career Highlights
Currently, Hans-Peter Elsässer is employed at Sanofi-a Ventis Deutschland GmbH, where he applies his expertise in the development of innovative pharmaceutical solutions. His work at the company has further advanced the field of gene therapy and cellular engineering, showcasing his commitment to improving medical science.
Collaborations
Throughout his career, Elsässer has collaborated with esteemed colleagues, including Thomas Kissel and Dagmar Fischer. These partnerships have fostered a collaborative environment that spurs innovation and drives forward the research initiatives at their organization.
Conclusion
Hans-Peter Elsässer exemplifies the spirit of innovation in the field of biotechnology. His groundbreaking patent on low molecular weight polyethylenimines highlights the significant impact that dedicated inventors can have on the advancement of medicine and technology. Through his work at Sanofi, as well as his collaborations with talented peers, he continues to push the boundaries of the possible in his field.